Physicians At St. David's Medical Center Among First In Nation To Implant Neurostimulator Technology For Advanced Heart Failure
PR93630
AUSTIN, Texas, Dec. 13, 2021 /PRNewswire=KYODO JBN/--
Doctors at St. David's Medical Center recently became among the first in the
U.S. to implant a new neurostimulator technology to help treat advanced heart
failure. The Barostim System is the only technology approved by the Food and
Drug Administration (FDA) to use the nervous system to control heart failure
and improve the function of the cardiovascular system.
The system features a programmable device that is placed under the patient's
collarbone and sends electrical pulses to baroreceptors, which detect changes
in pressure in the carotid artery. This triggers the baroreflex, the body's
main cardiovascular reflex, causing an autonomic, or involuntary, response to
the heart.
"When the device is activated, it sends impulses through an electrode to the
receptors in the carotid artery," Dr. Jeffrey Apple, a vascular surgeon with
Cardiothoracic and Vascular Surgeons who performed the procedure at St. David's
Medical Center, said. "This tricks the body into thinking that the sympathetic
and parasympathetic nervous systems are working correctly. The brain then
responds and sends messages to the body that the heart is working properly.
This relaxes the blood vessels, slows the heart rate and reduces fluid in the
body."
The therapy is designed to restore balance to the autonomic nervous system and
thereby reduce the symptoms of heart failure.
"This approach to heart failure is designed to improve patients' quality of
life, including those who remain symptomatic despite taking medications and
have no other device-based therapy options," Andrea Natale, M.D., F.A.C.C.,
F.H.R.S., F.E.S.C., cardiac electrophysiologist and executive medical director
of the Texas Cardiac Arrhythmia Institute at St. David's Medical Center, said.
"It allows them to live their everyday lives with fewer limitations."
SOURCE: St. David’s Medical Center
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。